Gyldendal ASA (OSL:GYL)
Norway · Delayed Price · Currency is NOK 440.00
0.00 (0.00%)
At close: Mar 13, 2026
Gyldendal ASA Market Cap
Gyldendal ASA has a market cap or net worth of 1.02 billion as of March 13, 2026. Its market cap has increased by 12.24% in one year.
Market Cap
1.02B
Enterprise Value
1.66B
Revenue
2.80B
Ranking
n/a
PE Ratio
11.93
Stock Price
440.00
Market Cap Chart
Since March 2, 1998, Gyldendal ASA's market cap has increased from 705.67M to 1.02B, an increase of 43.85%. That is a compound annual growth rate of 1.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.02B | -6.38% |
| Dec 30, 2025 | 1.08B | 19.29% |
| Dec 30, 2024 | 909.01M | -21.98% |
| Dec 29, 2023 | 1.17B | -14.41% |
| Dec 23, 2022 | 1.36B | -4.07% |
| Dec 30, 2021 | 1.42B | 23.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prosafe SE | 1.10B |
| Circio Holding ASA | 1.08B |
| ArcticZymes Technologies ASA | 1.08B |
| Eidesvik Offshore ASA | 1.06B |
| Nykode Therapeutics AS | 1.03B |
| Saga Pure ASA | 1.01B |
| S.D. Standard ETC | 975.54M |
| Vistin Pharma ASA | 944.54M |